NLS PHARMA

DEAD

Serial Number

79374467

Owner

NLS Pharmaceutics AG

Filing Date

Jun 20, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

NLS PHARMA Trademark

Serial Number: 79374467

NLS PHARMA is a trademark filed by NLS Pharmaceutics AG on June 20, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

NLS Pharmaceutics AG (8 trademarks)

Alter Postplatz 2

Entity Type: 99

Legal Representation

Correspondence Address

Baker McKenzie Zurich

Holbeinstrasse 30

CH-8034 Zürich,

SWITZERLAND

Trademark Details

Filing Date

June 20, 2023

Registration Date

Not Registered

Goods & Services

Scientific and technological services as well as research and design relating thereto

Pharmaceutical products; dietetic substances for medical use

Medical services; hygienic and beauty care for human beings

Filing History

DEATH OF INTERNATIONAL REGISTRATION

May 21, 2026 DETH

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Jan 4, 2025 OPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Dec 19, 2024 OPNS

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Dec 17, 2024 OPNR

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Oct 18, 2024 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Oct 18, 2024 ABN2

REFUSAL PROCESSED BY IB

Apr 29, 2024 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Apr 2, 2024 RFCS

REFUSAL PROCESSED BY MPU

Apr 2, 2024 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 15, 2024 RFCR

NON-FINAL ACTION WRITTEN

Mar 14, 2024 CNRT

ASSIGNED TO EXAMINER

Mar 8, 2024 DOCK

NEW REPRESENTATIVE AT IB RECEIVED

Feb 27, 2024 NREP

APPLICATION FILING RECEIPT MAILED

Jul 21, 2023 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 17, 2023 NWOS

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Jul 14, 2023 SDRC

Related Trademarks

More from this Owner

QUILIENCE

NOLAZOL

NLS PHARMA CONNECTING BRAINS

NOLAZOL

QUILIENCE

NLS PHARMA CONNECTING BRAINS

More in Same Class

GENETICS OVERRIDE

NLS PHARMA CONNECTING BRAINS